Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05674786 · ClinicalTrials.gov registry record · NA

Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction

A NA study of Vestibular Diseases and Sensation Disorders, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
8
Enrollment target
1
Study location

NCT05674786 is a NA study of Vestibular Diseases and Sensation Disorders that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 8 participants, below the 13,370-participant average among 6 other Vestibular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05674786, a NA study of Vestibular Diseases and Sensation Disorders, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
8 participants
Enrollment target
1
Study location

Study Summary

Although cochlear implants can restore hearing to individuals who have lost cochlear hair cell function, there is no widely available, adequately effective treatment for individuals suffering chronic imbalance, postural instability and unsteady vision due to bilateral vestibular hypofunction. Prior research focused on ototoxic cases has demonstrated that electrical stimulation of the vestibular nerve via a chronically implanted multichannel vestibular implant can partially restore vestibular reflexes that normally maintain steady posture and vision; improve performance on objective measures of postural stability and gait; and improve patient-reported disability and health-related quality of life. This single-arm open-label study extends that research to evaluate outcomes for up to 8 individuals with non-ototoxic bilateral vestibular hypofunction, yielding a total of fifteen adults (age 22-90 years at time of enrollment) divided as equally as possible between ototoxic and non-ototoxic cases.

Interventions

  • DEVICE Labyrinth Devices MVI™ Multichannel Vestibular Implant System

Study Locations (1)

Maryland

  • Johns Hopkins School of Medicine - Baltimore

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2023-02-28
Est. Completion 2027-03-31
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT05674786

The ClinicalTrials.gov registry entry for NCT05674786 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 13,370-participant average among 6 other Vestibular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 9 conditions, with Vestibular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Labyrinth Devices MVI™ Multichannel Vestibular Implant System is the first listed.

NCT05674786 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05674786 about?

NCT05674786 is a clinical study titled "Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction". Although cochlear implants can restore hearing to individuals who have lost cochlear hair cell function, there is no widely available, adequately effective treatment for individuals suffering chronic imbalance, postural instability and unsteady vision due to bilateral vestibular hypofunction. Prior ...

What is the current status of trial NCT05674786?

This trial is currently recruiting. It is a NA study. The enrollment target is 8 participants. The study started on 2023-02-28. Estimated completion is 2027-03-31.

What conditions does trial NCT05674786 study?

This clinical trial studies the following conditions: Vestibular Diseases, Sensation Disorders, Gentamicin Ototoxicity, Labyrinth Diseases, Bilateral Vestibular Hypofunction.

What interventions are being tested in trial NCT05674786?

The interventions under investigation include: Labyrinth Devices MVI™ Multichannel Vestibular Implant System (DEVICE).

Who is sponsoring clinical trial NCT05674786?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05674786 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vestibular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.